Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.03
-0.58 (-12.58%)
At close: Aug 15, 2025, 2:15 PM
Vivos Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.34M | 6.26M | 6.31M | 6.9M | 2.61M | 1.64M | 988K | 3.94M | 7.05M | 3.52M | 6.72M | 12.66M | 17.83M | 24.03M | 28.53M | 34.2M | 14.06M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 842.29K | 846.21K | 816.58K |
Other Long-Term Assets | 215K | 216K | 276K | 276K | 308K | 307K | 307K | 308K | 308K | 374K | 372K | 373K | 354K | 356K | 1.2M | 1.22M | 1.19M |
Receivables | 718K | 430K | 454K | 395K | 525K | 202K | 228K | 327K | 321K | 457K | 866K | 791K | 1.52M | 1.72M | 3.89M | 3.52M | 1.75M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -61.86K | n/a | n/a |
Other Current Assets | 547K | 783K | 634K | 554K | 475K | 616K | 769K | 1.07M | 1.35M | 1.45M | 2.12M | 2.06M | n/a | n/a | n/a | 1.67M | 927.63K |
Total Current Assets | 3.61M | 7.47M | 7.4M | 7.85M | 3.61M | 2.46M | 1.99M | 5.34M | 8.71M | 5.42M | 9.7M | 15.51M | 21.6M | 27.32M | 34.03M | 39.39M | 16.74M |
Property-Plant & Equipment | 4.26M | 4.38M | 4.45M | 4.48M | 4.63M | 4.7M | 4.75M | 4.81M | 4.78M | 4.78M | 5.17M | 5.32M | 4.43M | 2.83M | 2.6M | 2.29M | 1.06M |
Goodwill & Intangibles | 3.2M | 3.21M | 3.23M | 3.24M | 3.25M | 3.26M | 3.28M | 3.29M | 3.3M | 3.15M | 3.15M | 3.17M | 3.17M | 3.18M | 3.19M | 3.26M | 2.97M |
Total Long-Term Assets | 7.67M | 7.81M | 7.95M | 7.99M | 8.19M | 8.27M | 8.33M | 8.41M | 8.39M | 8.3M | 8.7M | 8.86M | 7.96M | 6.37M | 6.99M | 6.77M | 5.22M |
Total Assets | 11.28M | 15.28M | 15.35M | 15.84M | 11.8M | 10.73M | 10.32M | 13.75M | 17.1M | 13.72M | 18.4M | 24.38M | 29.56M | 33.69M | 41.02M | 46.16M | 21.95M |
Account Payables | 1.21M | 1.1M | 1.07M | 2.03M | 2.5M | 2.15M | 1.53M | 1.32M | 1.5M | 1.41M | 644K | 1.25M | 877K | 920K | 700.2K | 1.3M | 869.68K |
Deferred Revenue | 572K | 896K | n/a | 1.79M | 2.4M | 2.14M | 2.37M | 2.36M | 2.65M | 2.93M | 2.4M | 2.08M | 2.34M | 2.4M | 3.7M | 4.11M | 2.8M |
Short-Term Debt | n/a | 477K | n/a | 484K | 483K | 474K | n/a | 447K | 433K | 419K | 446K | 383K | 357K | 1.26M | 1.27M | 1.27M | 1.16M |
Other Current Liabilities | 672K | 1.51M | 1.51M | 467K | 879K | 560K | 1.6M | 2.52M | 1.66M | 280K | 840K | 1.06M | 3.76M | 1.46M | n/a | n/a | n/a |
Total Current Liabilities | 4.7M | 4.98M | 5.13M | 6.64M | 8.07M | 7.29M | 7.17M | 8.44M | 7.97M | 6.81M | 5.96M | 6.69M | 6.85M | 7.51M | 8.2M | 9.31M | 7.3M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.52M | 1.85M | 298K | n/a | n/a | 105.91K |
Other Long-Term Liabilities | 1.22M | 1.22M | 1.4M | 1.22M | 1.22M | 1.22M | 1.22M | 1.18M | n/a | n/a | 180K | -2.21M | -1.85M | 343K | 360K | 358.4K | 212.08K |
Total Long-Term Liabilities | 2.17M | 2.35M | 2.56M | 2.85M | 3.15M | 3.03M | 3.1M | 3.2M | 2.13M | 2.11M | 2.58M | 2.84M | 1.85M | 641K | 360K | 358.4K | 317.98K |
Total Liabilities | 6.88M | 7.33M | 7.68M | 9.49M | 11.22M | 10.32M | 10.27M | 11.64M | 10.11M | 8.92M | 8.54M | 9.54M | 8.7M | 8.15M | 8.56M | 9.67M | 7.61M |
Total Debt | 1.4M | 1.51M | 1.64M | 1.76M | 1.88M | 2M | 2.1M | 2.21M | 2.31M | 2.41M | 2.85M | 2.91M | 2.21M | 1.63M | 1.27M | 1.27M | 1.27M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 2K | 2.3K | 2.28K | 1.82K |
Retained Earnings | -108.05M | -104.19M | -101.36M | -98.74M | -96.81M | -93.05M | -88.79M | -86.7M | -81.17M | -79.47M | -73.38M | -67.95M | -61.14M | -55.62M | -48.23M | -42.78M | -38.73M |
Comprehensive Income | n/a | n/a | n/a | n/a | -0.00 | n/a | 0.00 | -0.00 | n/a | n/a | -0.00 | n/a | 0.00 | 0.00 | n/a | n/a | n/a |
Shareholders Equity | 4.41M | 7.95M | 7.67M | 6.35M | 582K | 411K | 46K | 2.11M | 6.99M | 4.8M | 9.86M | 14.84M | 20.86M | 25.54M | 32.47M | 36.48M | 14.34M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 842.29K | 846.21K | 816.58K |